Antimicrobial drugs for use in livestock domestic sales by drug U.S. 2023

This statistic depicts the domestic sales of antimicrobial drugs for usage in livestock in the United States in 2022 and 2023, by drug class. Domestic sales for sulfonamides amounted to around 268,000 kilograms of active ingredient in 2023.

Domestic sales of antimicrobial drugs for use in livestock in the United States in 2022 and 2023, by drug class (in kilograms)

Drug class	2022	2023
Aminoglycosides	373,612	355,524
Cephalosporins	29,492	28,345
Fluoroquinolones	25,125	27,230
Lincosamides	197,400	162,683
Macrolides	567,657	532,072
Penicillins	618,512	614,619
Sulfonamides	312,186	267,846
Tetracyclines	4,056,479	4,069,793
Ionophores	4,182,139	4,030,892
Pleuromutilins	176,876	168,554
NIR*	630,766	670,414

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

October 2024

More information

Region

United States

Survey time period

2022 and 2023

Supplementary notes

Includes antimicrobial drug applications which are approved and labeled for use in both food-producing animals (e.g., cattle and swine) and nonfood-producing animals (e.g., dogs and cats).
kg = kilogram of active ingredient. Antimicrobials which were reported in International Units (IU) (e.g., Penicillins) were converted to kg. Antimicrobial class includes drugs of different molecular weights, with some drugs reported in different salt forms.
Only includes exports of FDA-approved, US-labeled antimicrobial drugs approved for use in food-producing animals.
* NIR = Not Independently Reported. Antimicrobial classes for which there were fewer than three distinct sponsors actively marketing products domestically are not independently reported. These classes include the following: Amphenicols, Diaminopyrimidines, Fluoroquinolones, Polymyxins, and Streptogramins.

Citation formats